A Study of BGM0504 in Participants with Type 2 Diabetes

This study is testing a new drug called BGM0504 (a GLP-1 receptor agonist) in people with type 2 diabetes who are already taking metformin (with or without a sulfonylurea) but still have poor blood sugar control. It aims to see whether BGM0504 improves blood sugar levels safely. **You may be eligible if...** - You have type 2 diabetes - You are on a stable dose of metformin (or metformin plus a sulfonylurea) for at least 8 weeks - Your HbA1c is between 7.5% and 11.0% - Your BMI is 23 or above - Your weight has been stable (within ±5%) for at least 3 months **You may NOT be eligible if...** - You have type 1 diabetes - You have had cancer in the past 5 years (some exceptions apply) - You have had pancreatitis - You are allergic to GLP-1 receptor agonists - You are pregnant or breastfeeding - You have a history of alcohol or substance abuse Talk to your doctor to see if this trial is right for you.